Lozen Pharma Private Limited, a active private limited company, was established on 14 January 2009 in Savanur, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239KA2009PTC068381. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹40.00 Cr and a paid-up capital of ₹30.80 Cr.
It upholds a compliant status. Employing 88 professional, Its leadership includes Arjun Gautam Ashra (Director), Gautam Rasiklal Ashra (Director), Jugal Parekh (Director). Past directors included Gajanan Murlidhar Dixit, Vipul Babulal Thakkar, Arjun Gautam Ashra. It holds ₹13.98 Cr open charges and ₹1.45 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Kssidc Industrial Estate, Shiggaon Road,, Savanur, Karnataka, 581118.
U24239KA2009PTC068381
068381
14 January 2009
₹40.00 Cr
₹30.80 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Lozen Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arjun Gautam Ashra | Director | 25 Oct 2016 | Current |
| Gautam Rasiklal Ashra | Director | 11 Aug 2023 | Current |
| Jugal Parekh | Director | 27 Nov 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Feb 2021 | Past |
| Pramod Abcsdd | Director | 26 Jun 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2023 | Past |
| Pramod Abcsdd | Managing Director | 07 Aug 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lozen Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 69.08% increase. The company also saw a substantial improvement in profitability, with a 660.67% increase in profit. The company's net worth Soared by an impressive increase of 24.24%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Lozen Pharma had a promoter holding of 76.31% and a public holding of 23.69%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹139,753,823.00
₹14,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Sep 2025 | Axis Bank Limited | ₹10.00 M | Open |
| 28 Apr 2025 | Others | ₹1.81 Cr | Open |
| 21 Jun 2024 | Others | ₹11.17 Cr | Open |
| 18 Aug 2016 | Others | ₹1.00 Cr | Satisfied |
| 22 Dec 2011 | Karnataka State Financial Corporation | ₹4.50 M | Satisfied |
Explore comprehensive loan charge details -
Lozen Pharma has a workforce of 88 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Lozen Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lozen Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Axis Bank Limited amounted to Rs. 1.00 Cr with Charge ID 101159813 was registered on 01 Sep 2025. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 1.81 Cr with Charge ID 101114684 was registered on 28 Apr 2025. was completed.
Progress on Lozen Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity A charge with Others amounted to Rs. 11.17 Cr with Charge ID 100953641 was registered on 21 Jun 2024. was completed.
Progress on Lozen Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was documented.
The activity Gautam Rasiklal Ashra was appointed as a Director was appointed as a Director on 11 Aug 2023 & has been associated with this company since 2 years 3 months . was completed.
The CIN of Lozen Pharma Private Limited is U24239KA2009PTC068381.
Lozen Pharma Private Limited is headquartered at Kssidc Industrial Estate, Shiggaon Road,, Savanur, Karnataka, 581118.
Lozen Pharma Private Limited was incorporated on 14 January 2009.
The current directors of Lozen Pharma Private Limited are
The primary industry of Lozen Pharma Private Limited is Manufacturing.
Lozen Pharma Private Limited is unlisted.
The authorized capital of Lozen Pharma Private Limited is ₹40.00 Cr, and the paid-up capital is ₹30.80 Cr.
The compliance status of Lozen Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX